Light and mild redux: heated tobacco products’ reduced exposure claims are likely to be misunderstood as reduced risk claims
Open Access
- 12 September 2018
- journal article
- research article
- Published by BMJ in Tobacco Control
- Vol. 27 (Suppl 1), s87-s95
- https://doi.org/10.1136/tobaccocontrol-2018-054324
Abstract
Introduction Heated tobacco products (HTPs) are being marketed in several countries around the world with claims that they are less harmful than combusted cigarettes, based on assertions that they expose users to lower levels of toxicants. In the USA, Philip Morris International (PMI) has submitted an application to the Food and Drug Administration (FDA) in 2016 seeking authorisation to market its HTPs, IQOS, with reduced risk and reduced exposure claims. Methods We examined the PMI’s Perception and Behavior Assessment Studies evaluating perceptions of reduced risk claims that were submitted to the FDA and made publicly available. Results Qualitative and quantitative studies conducted by PMI demonstrate that adult consumers in the USA perceive reduced exposure claims as reduced risk claims. Conclusion The data in the PMI modified risk tobacco product IQOS application do not support reduced risk claims and the reduced exposure claims are perceived as reduced risk claims, which is explicitly prohibited by the FDA. Allowing PMI to promote IQOS as reduced exposure would amount to a legally sanctioned repeat of the ‘light’ and ‘mild’ fraud which, for conventional cigarettes, is prohibited by the US law and the WHO Framework Convention on Tobacco Control.Keywords
Funding Information
- National Cancer Institute
- National Institute on Drug Abuse
This publication has 34 references indexed in Scilit:
- Consumer understanding of cigarette emission labellingEuropean Journal of Public Health, 2010
- "I always thought they were all pure tobacco": American smokers' perceptions of "natural" cigarettes and tobacco industry advertising strategiesTobacco Control, 2007
- Taking ad-Vantage of lax advertising regulation in the USA and Canada: Reassuring and distracting health-concerned smokersSocial Science & Medicine (1982), 2006
- Smoking Topography, Brand Switching, and Nicotine Delivery: Results from an In vivo StudyCancer Epidemiology, Biomarkers & Prevention, 2005
- An extremely compensatible cigarette by design: documentary evidence on industry awareness and reactions to the Barclay filter design cheating the tar testing systemTobacco Control, 2005
- The tar reduction study: randomised trial of the effect of cigarette tar yield reduction on compensatory smoking.Thorax, 1995
- Low tar, high toll.American Journal of Public Health, 1992
- Self-selected blocking of vents on low-yield cigarettesPharmacology Biochemistry and Behavior, 1989
- Relationship between cigarette yields, puffing patterns, and smoke intake: evidence for tar compensation?BMJ, 1982
- The misuse of 'less-hazardous' cigarettes and its detection: hole-blocking of ventilated filters.American Journal of Public Health, 1980